Heart Failure Induced by Perinatal Ablation of Cardiac Myosin Light Chain Kinase

Yasmin F K Islam1, Ryan Joseph1, Rajib R Chowdhury1

  • 1Department of Physiology and Functional Genomics, University of Florida Gainesville, FL, USA.

Frontiers in Physiology
|November 12, 2016
PubMed

Insights

Perinatal knockout of cardiac myosin light chain kinase (cMLCK) in mice leads to heart failure with elongated cardiomyocytes. This finding highlights developmental stage-dependent compensation in cardiac gene function.

Area of Science:

  • Cardiovascular Biology
  • Developmental Biology
  • Genetics

Background:

  • Germline gene knockouts are crucial for understanding gene function but can reveal compensatory mechanisms.
  • Cardiac myosin light chain kinase (cMLCK) ablation shows varied cardiac phenotypes depending on the developmental stage of ablation.
  • Hypothesis: Perinatal cMLCK ablation results in heart failure distinct from germline or adult-onset ablation.

Purpose of the Study:

  • To investigate the cardiac phenotype resulting from perinatal ablation of cMLCK.
  • To compare the effects of perinatal cMLCK ablation with germline and adult-onset ablation models.

Main Methods:

  • Perinatal knockout of the *Mylk3* gene (encoding cMLCK) was induced in mice via tamoxifen injection on day 19 of gestation.
  • Cardiac function, heart weight to body weight ratio, body weight, and cardiomyocyte morphology were assessed at postnatal day 19.
  • Gene expression analysis was performed to evaluate fetal gene markers.

Main Results:

  • Perinatal cMLCK knockout mice exhibited reduced cardiac contractility (fractional shortening) and increased heart weight to body weight ratio.
  • These mice also showed reduced body weight and elongated cardiomyocytes without thickening.
  • Increased expression of fetal genes was observed, indicating a distinct cardiac response.

Conclusions:

  • Perinatal cMLCK ablation causes significant cardiac dysfunction, including reduced contractility and altered cardiomyocyte structure.
  • The observed phenotype differs from both germline and adult-inducible cMLCK knockout models, emphasizing developmental timing in compensatory responses.
  • This study provides insights into the role of cMLCK during perinatal cardiac development and adaptation.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
607
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
700
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
571
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
526